Appraisal of antivenom production in public laboratories in Latin America during the first semester of 2020: The impact of COVID-19

PLoS Negl Trop Dis. 2021 Jun 17;15(6):e0009469. doi: 10.1371/journal.pntd.0009469. eCollection 2021 Jun.

Authors

José María Gutiérrez¹, Larissa Zanette², Marco Antonio Natal Vigilato², Julio Cesar Augusto Pompei², Diogo Martins³, Hui Wen Fan⁴; Latin American Network of Public Antivenom Manufacturing Laboratories (RELAPA)

Affiliations

¹ Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.
² Centro Panamericano de Fiebre Aftosa, Organización Panamericana de la Salud, Rio de Janeiro, Brazil.
³ Wellcome Trust, London, United Kingdom.
⁴ Instituto Butantan, São Paulo, Brazil.

No abstract available

MeSH terms

Antivenins / biosynthesis*
COVID-19*
Humans
Laboratories / organization & administration*
Latin America
Manufacturing and Industrial Facilities

Substances

Antivenins

Grants and funding

The authors received no specific funding for this work.